logo.png
Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up
April 11, 2023 05:00 ET | Paradigm Biopharmaceuticals
MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australia’s Paradigm Biopharmaceuticals Ltd (ASX:PAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium...
MicrosoftTeams-image (5).png
Radiopharmaceutical Theranostics Market Size to Cross USD 12.4 Bn by 2031 | Transparency Market Research
April 03, 2023 17:30 ET | Transparency Market Research
Wilmington, Delaware, United States, April 04, 2023 (GLOBE NEWSWIRE) -- The global radiopharmaceutical theranostics market was valued at USD 3.0 Bn in 2022 and is projected to reach USD 12.4 Bn by...
MnM_logo_TM_JPG.JPG
Biomarkers Market is Expected to Reach $104.0 billion | MarketsandMarkets.
March 31, 2023 09:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, March 31, 2023 (GLOBE NEWSWIRE) -- The future of biomarkers is expected to be a very promising one. As new technologies and techniques continue to emerge, the use of biomarkers will become...
Biomarkers Market Size to Surpass USD 97.51 Billion by 2026 | With 12.1% CAGR
February 06, 2023 07:44 ET | Fortune Business Insights
Pune, India, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The global Biomarkers Market size stood at USD 39.10 billion in 2018. The market is slated to expand USD 97.51 billion by 2026, exhibiting a CAGR of...
Inotiv_Logo_CMYK.png
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 08, 2022 16:10 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
TIP_link_300x300.jpg
With 13% of CAGR, Neurological Biomarker Market to Gain $14+ Billion Revenue by 2027 | Exclusive Report by The Insight Partners
November 14, 2022 06:58 ET | The Insight Partners
New York, Nov. 14, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "Neurological Biomarker Market Size, Share, Growth, Trends and Forecast to 2027 – COVID-19 Impact and...
Vantage Market Research.png
Cancer Biomarkers Market Size & Share to Surpass $31.8 Bn by 2028 | Vantage Market Research
November 10, 2022 11:49 ET | Vantage Market Research
WASHINGTON, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The global Cancer Biomarkers Market was valued at $12.1 Billion in 2021 and is expected to reach $31.8 Billion by 2028, registering a CAGR of 17.5%...
Biomarkers Market Size Worth USD 88,605.25 Million by 2030 at 10.80% CAGR - Report by Market Research Future (MRFR)
October 28, 2022 09:30 ET | Market Research Future
New York, USA, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Biomarkers Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Biomarkers Market Information by...
Elixiron Immunotherapeutics Receives Grant From the Alzheimer's Association to Trial Microglia-Targeting Immunotherapy
July 12, 2022 11:01 ET | Elixiron Immunotherapeutics
SAN FRANCISCO, July 12, 2022 (GLOBE NEWSWIRE) -- Elixiron Immunotherapeutics, a clinical stage drug development company announced today that it has received a new grant from the Alzheimer's...
researchdrivelogo.jpg
North America DNA Sequencing Market Anticipated to Garner a Revenue of $9,154 million and Grow at a Healthy CAGR of 15.9% during the Estimated Timeframe from 2019 to 2025 [200-Pages] | Revealed by Research Dive
June 28, 2022 09:00 ET | Research Dive
New York, USA, June 28, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the North America DNA Sequencing Market is envisioned to generate a revenue of $9,154 million and...